Börse Express – ROUNDUP: B. Braun positions itself against buying Rhön through Asklepios

The major Rhön-Klinikum shareholder
B. Braun Melsungen opposes the planned one
Acquisition of the clinic operator by the competitor Asklepios in
Position. B. Braun called for an extraordinary general meeting
including debate and, if necessary, decision-making on the
Offer from Asklepios, such as Rhön Clinic on Saturday in Bad Neustadt
announced on the Saale. B. Braun also demands a high one
Distribution of profits in the form of an advance dividend. This demand
which would lead to a high outflow of capital
Asklepios with a view of the financial situation of Rhön and the
Corona crisis as “irresponsible”.

The pharmaceutical and medical supplies provider B. Braun also wants that
in the future, resolutions at the Annual General Meeting will only be more than 75
Percentage of votes cast or represented
Share capital are possible. Since B. Braun more than a quarter of the
Holds shares, the company could attend a general meeting
so that all decisions block. At the same time he wants
Major shareholder dismissing numerous members of the supervisory board,
including that of the company’s founder Eugen Münch. Should the
extraordinary shareholders’ meeting is called, the
Asklepios’ schedule is delayed in the takeover.

Then the acceptance period for the takeover bid would be ten
Extend weeks from the publication of the offer document.
Asklepios actually wanted the takeover in the second quarter
to lock. The planned transaction has been going on for a year
Tug of war for Rhön ahead. That’s how Rhön founder Eugen Münch wanted it
2012 the company with Fresenius Helios
merge, whereupon Asklepios and B. Braun joined Rhön
and prevented a comprehensive deal. In the end it was 40
Hospitals, however, a large part of the Rhön clinics
Helios gone.

At that time B.Braun had already feared for its market position. And
it would not look any different at the moment, too
Asklepios and Rhön are two leading hospital groups in Germany
unite behind the market leader Fresenius Helios. The common one
Asklepios and Münch became known at the end of February 2020
given. Accordingly, the shares of Asklepios, from
Rhön founder Eugen Münch and his wife in one
Joint venture bundled. After buying an additional one
Asklepios’ share package brings it to the joint venture
meanwhile on more than 50 percent of the voting rights.

Asklepios also wants an offer from the other Rhön shareholders
Submit 18 euros per share. That is 25 percent more than that
Papers had cost before announcing plans, and something like that
much as they currently cost on the stock exchange. But here too B.
Braun thwarted the plans and asked for payment
Dividend discount of 2 euros per Rhön-Klinikum share. That would be one
Multiples of the amount that the company has for the past year
has provided. At the end of March, Rhön Klinikum announced that
Dividend increased by four due to last year’s profit decline
Want to cut 25 cents.

Since the company in the current year with high costs for new
Conditions are calculated and the consequences of the corona pandemic are not
are foreseeable, the potential buyer Asklepios holds the
Irresponsible dividend claim. This would make 134
Million euros will be paid to the shareholders.
“Distributions are in the order of magnitude required by B. Braun
in stark contradiction to the economic situation and the expected
Development of the company, “said Asklepios on Saturday.” The
B. Braun’s demands therefore immediately endanger stability
of the company and job security. “

Since B. Braun with CFO Annette Beller on the Rhön Supervisory Board
is represented and the effects of such a capital deduction exactly
Asklepios makes serious allegations in the direction of the
other major shareholder. The assumption arises that B.
Brown regardless of the stability of Rhön, his
Want to withdraw funds and employees. “Just before
given the fact that politics is making great efforts to
Protecting hospitals in the corona crisis with tax money is that
B. Braun’s intentions, high under the corona reserve
Having dividends paid out irresponsible. “/ Mis / zb / nas

 ISIN  DE0007042301  DE0005785604

AXC0061 2020-04-18 / 15:22

Copyright dpa-AFX Wirtschaftsnachrichten GmbH. All rights reserved. Redistribution, republication or permanent storage without the express prior consent of dpa-AFX is not permitted.

– .